Newsletter
Anticoagulation in Patients Younger Than 21 Years of Age, Semaglutide vs Liraglutide and Body Weight, COPD Screening in Low- and Middle-Income Countries, and more

JAMA Editor’s Summary

Anticoagulation in Patients Younger Than 21 Years of Age, Semaglutide vs Liraglutide and Body Weight, COPD Screening in Low- and Middle-Income Countries, and more

Editor’s Summary by Christopher Muth, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the issue.
January 11, 2022

Anticoagulation in Patients Younger Than 21 Years of Age, Semaglutide vs Liraglutide and Body Weight, COPD Screening in Low- and Middle-Income Countries, and more

Editor’s Summary by Christopher Muth, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the January 11, 2022 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Creating Healthcare IT with Cliff Illig, Co-founder of Cerner Corporation This episode is hosted by Day Zero Advisory Council Member Donald Trigg, Former President, Cerner Corporation.